434 related articles for article (PubMed ID: 35849397)
1. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
[TBL] [Abstract][Full Text] [Related]
2. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
3. Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.
Silverman TB; Vanegas A; Marte A; Mata J; Sin M; Ramirez JCR; Tsai WY; Crew KD; Kukafka R
BMC Health Serv Res; 2018 Aug; 18(1):633. PubMed ID: 30103738
[TBL] [Abstract][Full Text] [Related]
4. Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
Arun BK; Peterson SK; Sweeney LE; Bluebond RD; Tidwell RSS; Makhnoon S; Kushwaha AC
Cancer; 2022 Jan; 128(1):94-102. PubMed ID: 34424535
[TBL] [Abstract][Full Text] [Related]
5. Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.
Kinney AY; Howell R; Ruckman R; McDougall JA; Boyce TW; Vicuña B; Lee JH; Guest DD; Rycroft R; Valverde PA; Gallegos KM; Meisner A; Wiggins CL; Stroup A; Paddock LE; Walters ST
Contemp Clin Trials; 2018 Oct; 73():123-135. PubMed ID: 30236776
[TBL] [Abstract][Full Text] [Related]
6. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian.
Hessock M; Brewer T; Hutson S; Anderson J
Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425
[TBL] [Abstract][Full Text] [Related]
7. Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center.
Zang B; Helms M; Besch L; Kalmbach N; Stegen S; Blohmer JU; Speiser D
Arch Gynecol Obstet; 2023 May; 307(5):1585-1592. PubMed ID: 36307613
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: design of a multicenter randomized clinical trial.
Wevers MR; Ausems MG; Verhoef S; Bleiker EM; Hahn DE; Hogervorst FB; van der Luijt RB; Valdimarsdottir HB; van Hillegersberg R; Rutgers EJ; Aaronson NK
BMC Cancer; 2011 Jan; 11():6. PubMed ID: 21219598
[TBL] [Abstract][Full Text] [Related]
9. Identifying Mediators of Intervention Effects Within a Randomized Controlled Trial to Motivate Cancer Genetic Risk Assessment Among Breast and Ovarian Cancer Survivors.
An J; Lu SE; McDougall J; Walters ST; Lin Y; Heidt E; Stroup A; Paddock L; Grumet S; Toppmeyer D; Kinney AY
Ann Behav Med; 2023 Oct; 57(11):965-977. PubMed ID: 37658805
[TBL] [Abstract][Full Text] [Related]
10. Pilot study of a culturally sensitive intervention to promote genetic counseling for breast cancer risk.
Henderson V; Madrigal JM; Kendall LC; Parekh P; Newsome J; Chukwudozie IB; Comer-Hagans L; Coffey V; Grumbach G; Spencer S; Rodgers C; Kaur R; Balay L; Maga T; Ramamonjiarivelo Z; Balthazar C; Winn R; Watson K; Odoms-Young A; Hoskins KF
BMC Health Serv Res; 2022 Jun; 22(1):826. PubMed ID: 35752812
[TBL] [Abstract][Full Text] [Related]
11. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
[TBL] [Abstract][Full Text] [Related]
12. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Armstrong K; Micco E; Carney A; Stopfer J; Putt M
JAMA; 2005 Apr; 293(14):1729-36. PubMed ID: 15827311
[TBL] [Abstract][Full Text] [Related]
13. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial.
Kautz-Freimuth S; Redaèlli M; Shukri A; Kentenich H; Simic D; Mildenberger V; Schmutzler R; Rhiem K; Stock S
BMC Med Inform Decis Mak; 2023 Oct; 23(1):223. PubMed ID: 37845719
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial.
Kautz-Freimuth S; Redaèlli M; Isselhard A; Shukri A; Vodermaier A; Rhiem K; Schmutzler R; Stock S
Trials; 2022 Feb; 23(1):157. PubMed ID: 35172875
[TBL] [Abstract][Full Text] [Related]
16. Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care.
Head M; Cohn B; Wernli KJ; Palazzo L; Ehrlich K; Matson A; Knerr S
Womens Health Issues; 2024; 34(3):268-275. PubMed ID: 38448251
[TBL] [Abstract][Full Text] [Related]
17. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
[TBL] [Abstract][Full Text] [Related]
18. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
[TBL] [Abstract][Full Text] [Related]
19. Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial: A Randomized Clinical Trial.
Swisher EM; Rayes N; Bowen D; Peterson CB; Norquist BM; Coffin T; Gavin K; Polinsky D; Crase J; Bakkum-Gamez JN; Blank SV; Munsell MF; Nebgen D; Fleming GF; Olopade OI; Law S; Zhou A; Levine DA; D'Andrea A; Lu KH
JAMA Oncol; 2023 Nov; 9(11):1547-1555. PubMed ID: 37707822
[TBL] [Abstract][Full Text] [Related]
20. Lung Cancer Screening Decision Aid Designed for a Primary Care Setting: A Randomized Clinical Trial.
Schapira MM; Hubbard RA; Whittle J; Vachani A; Kaminstein D; Chhatre S; Rodriguez KL; Bastian LA; Kravetz JD; Asan O; Prigge JM; Meline J; Schrand S; Ibarra JV; Dye DA; Rieder JB; Frempong JO; Fraenkel L
JAMA Netw Open; 2023 Aug; 6(8):e2330452. PubMed ID: 37647070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]